Seminal plasma regulation of the post-coital inflammatory response in the human cervix by Sharkey, David James
Seminal plasma regulation of the 

post-coital inflammatory response in 

the human cervix 

David James Sharkey 
Research Centre for Reproductive Health, 

Department of Obstetrics and Gynaecology, 





A thesis submitted to the University of Adelaide in fulfilment of the requirements for . 




In mice and other mammalian species, deposition of semen into the female reproductive tract 
elicits a local inflammatory response. Whether a comparable response occurs within the human cervix 
has not previously been studied. The experiments described in this thesis demonstrate, using cervical 
tissue biopsies taken before and after intercourse, that exposure to semen elicits an infiltration of 
leukocytes into the cervical tissue of peri-ovulatory women. Immunohistochemical analysis identified 
macrophages and dendritic cells as the predominant leukocytes recruited into the cervical epithelium and 
stroma following intercourse. Cytotoxic I suppressor T lymphocytes and memory T cells were also 
increased. Comparable responses were not detected Iollowing condom-protected intercourse. 
Quantitative real-time PCR was performed on duplicate tissue biopsies to investigate the molecular 
regulation of this response. Expression of GM-CSF, a potent stimulator of myeloid cell recruitment, was 
found to increase by 2.5-fold following unprotected intercourse. Trends towards increased IL-6 and IL-8 
mRNA were also observed. Condom-protected intercourse did not activate cytokine expression, further 
suggesting that exposure to semen, as opposed to mechanical trauma, provides the inflammatory 
stimulus. 
In an in vitro model using the immortalised Ect-1 cell line, TGFY was identified as a candidate 
active seminal factor. All three TGFY isoforms were capable of mimicking the stimulatory ability of 
seminal plasma in Ect-1 cells and were comparable in their capacity to stimulate both GM-CSF and IL-6 
expression in a dose-responsive manner. The addition of TGFY isoform-specific neutralising antibodies 
inhibited seminal plasma-induced increases in these cytokines. However TGFY was unable to stimulate 
IL-8 production. Addition of IFNy was found to strongly inhibit TGFY-stimulated GM-CSF production, and 
19-0H PGE1 was found to increase IL-6 and IL-8, but not GM-CSF production. Responses to seminal 
plasma constituents were almost exactly replicated in primary cultures of human ectocervical cells. 
These results identify TGFY as the major active constituent in human seminal plasma and indicate that 
other seminal agents, 19-0H PGE1 and IFNy, interact with TGFY to differentially regulate cervical 
cytokine expression. 
Finally, whether human seminal plasma cytokine content was associated with fertility in men was 
examined. No relationship between seminal plasma TGFY1, TGFY2, TGFY3, IL-8 or bacterial endotoxin 
content and fertility status was observed. However, there was an increased likelihood of high IFNy 
Sharkey 
content in the male partners of couples experiencing infertility, most notable in recurrent miscarriage. The 
discriminating value of IFNy was increased when evaluated as a ratio of total TGFf3 content. 
Inflammatory changes after exposure of the female reproductive tract to seminal plasma are 
implicated in 'conditioning' the maternal immune response, to facilitate successful embryo implantation 
and pregnancy. The studies described in this thesis provide a mechanistic basis for the observations 
linking exposure to semen with pregnancy success in humans and have expanded our knowledge of the 
cellular and molecular events that occur within the female reproductive tract following intercourse. 
Seminal plasma can therefore no longer be thought of as merely a transport medium for spermatozoa, 
rather as a means for communication between the male and female reproductive tissues, potentially 
required for optimal pregnancy success. 
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